-

HighRes® and Opentrons® Announce Strategic Partnership to Launch the Industry’s First AI Agent-to-Agent Lab Automation Workflow

Joint collaboration unites powerful robotics with AI-driven orchestration to redefine how labs scale automation

BEVERLY, Mass. & NEW YORK--(BUSINESS WIRE)--HighRes, Inc., a leader in laboratory automation and orchestration software, and Opentrons Labworks, Inc., the leading laboratory robotics company building the physical infrastructure for AI-driven autonomous science, today announced a strategic partnership to co-develop and demonstrate the industry’s first AI agent-to-agent laboratory workflow. Together, the companies are introducing a new model for workflow automation that connects intuitive, modular robotics with enterprise-grade orchestration and AI-ready infrastructure.

With HighRes, we’re creating a tightly integrated system where AI-driven intent is translated directly into reliable, physical execution at the bench.

Share

This collaboration brings Opentrons’ flexible, high-throughput Opentrons Flex® robotic platforms and OpentronsAI, together with the FlexPod™ Configurable Lab Automation Platform and Cellario®, HighRes’ industry-leading scheduling and orchestration software, enabling scientists to adopt automation quickly and scale seamlessly as workflows grow in complexity.

“We see Opentrons as an innovative partner that has driven democratization of lab automation through cost-effective, capable liquid handling and more accessible, agentic protocol creation,” said Ira Hoffman, CEO of HighRes. “We share that philosophy, and together we’re unlocking greater speed and access for scientists while maintaining the reliability and repeatability life science organizations demand.”

“This is a joint effort to rethink how automation actually gets used in real labs,” said James Atwood, CEO of Opentrons. “With HighRes, we’re creating a tightly integrated system where AI-driven intent is translated directly into reliable, physical execution at the bench.”

Debuting the First Agent-to-Agent Workflow at SLAS 2026

At SLAS 2026, HighRes and Opentrons will debut a live demonstration of the industry’s first agent-to-agent lab workflow, showing how autonomous software agents communicate across platforms to plan and execute experiments using natural language.

The demonstration will feature:

  • Agent-to-agent orchestration, leveraging HighRes orchestration software, OpentronsAI, and the Opentrons MCP server to generate semi-automated qPCR workflows from natural-language input.
  • A unified digital lab experience, integrating experiment planning, execution, and data management.
  • A scalable automation pathway, extending accessible, bench-friendly robotics into fully orchestrated lab ecosystems.
  • An AI-ready operational model, unifying data, devices, and decisions through a shared orchestration layer.

Designed for Interoperability and Scale

Interoperability underpins the partnership, with both companies committed to open, extensible APIs and transparent system architectures. This approach enables Opentrons’ robotic platforms to operate alongside instruments from multiple vendors within HighRes’ orchestration environment.

Visit HighRes at Booth #1408 and Opentrons at Booth #912 at SLAS 2026 in Boston, from February 9 to 11, to see the integration in action.

About HighRes

HighRes is the leading global lab automation company, empowering scientists to create results by connecting instrumentation, software and data – from anywhere in the world. HighRes partners and clients achieve unprecedented levels of productivity while continually adapting their solutions to dynamic scientific, technological and organizational structures.

About Opentrons

Opentrons Labworks Inc. builds laboratory robots that automate experiments for drug discovery, genomics, and diagnostics. With more than 10,000 systems deployed at every top-20 U.S. research university and 14 of the top 15 global biopharma companies, Opentrons enables a continuous learning loop between AI models and real-world experimentation. The company is backed by SoftBank and Khosla Ventures and is headquartered in New York. For more information, visit opentrons.com.

Contacts

Opentrons Media Contact
Patrick Schmidt
Opentrons@consortpartners.com

HighRes Media Contact
Tom Rawlins
trawlins@highresbio.com

Opentrons Labworks, Inc. Logo
Opentrons Labworks, Inc. Logo

Opentrons Labworks, Inc.


Release Versions

Contacts

Opentrons Media Contact
Patrick Schmidt
Opentrons@consortpartners.com

HighRes Media Contact
Tom Rawlins
trawlins@highresbio.com

More News From Opentrons Labworks, Inc.

Opentrons Global Robotics Chief, James Atwood, Named Chief Executive Officer

NEW YORK--(BUSINESS WIRE)--Opentrons Labworks, Inc., a laboratory robotics company building the physical infrastructure for AI-driven autonomous science, today announced the promotion of James Atwood to Chief Executive Officer. Atwood assumed the role of CEO in July 2025. He has led Opentrons’ Robotics Business Unit since April 2023, overseeing the expansion of the company’s installed base to more than 10,000 robotic systems deployed globally across academic, biotech, and pharmaceutical laborat...

Neochromosome and Opentrons Introduce Automated Antibody Discovery Solution, Enabling Labs to Achieve Rapid, Cost-Effective In-House Development

LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc., recognized worldwide for accessible lab automation with more than 10,000 robotic systems deployed, and Neochromosome, Inc., its subsidiary specializing in products unlocked through genome-scale cell engineering, today announced the Opentrons Flex® neoSwitch™ Workstation powered by the Neochromosome® neoSwitch platform for in-house antibody discovery. The Workstation enables labs to automate critical steps of the neoSwitch antibo...

Opentrons Announces a Flex Proteomics Workstation for Automated Mass Spectrometry Sample Prep

LONG ISLAND CITY, N.Y.--(BUSINESS WIRE)--Opentrons Labworks, Inc. today introduced its Opentrons Flex® Proteomics Workstation, an automated system for common proteomics workflows, including preparing mass spectrometry (MS) samples at a cost significantly below the six-figure range common in proteomics automation. It automates steps such as protein digestion (SP3), quantification, labeling, and purification, streamlining processes that typically require significant hands-on time for bench scient...
Back to Newsroom